Key result
This review describes the structural data and core principles of the three known types of RNA-guided nucleic acid interference mechanisms in CRISPR-Cas immunity.
This review summarizes the structural data and core principles of the three known types of RNA-guided nucleic acid interference mechanisms in CRISPR-Cas systems.
Summarizes CRISPR-Cas structural principles; leaves open therapeutic extensions for cardiovascular gene editing.
The pathway of CRISPR-Cas immunity redefines the roles of RNA in the flow of genetic information and ignites excitement for next-generation gene therapy tools. CRISPR-Cas machineries offer a fascinating set of new enzyme assemblies from which one can learn principles of molecular interactions and chemical activities. The interference step of the CRISPR-Cas immunity pathway congregates proteins, RNA, and DNA into a single molecular entity that selectively destroys invading nucleic acids. Although much remains to be discovered, a picture of how the interference process takes place is emerging. This review focuses on the current structural data for the three known types of RNA-guided nucleic acid interference mechanisms. In it, we describe key features of individual complexes and we emphasize comparisons across types and along functional stages. We aim to provide readers with a set of core principles learned from the three types of interference complexes and a deep appreciation of the diversity among them.
No takes yet. Share an insight, caveat, or question.
Tsui et al. (2015) conducted a review in CRISPR-Cas immunity. This review describes the structural data and core principles of the three known types of RNA-guided nucleic acid interference mechanisms in CRISPR-Cas immunity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: